Proclemer Alessandro, Zecchin Massimo, Zanotto Gabriele, D'Onofrio Antonio, De Ponti Roberto, Pietro Riccicon la Collaborazione di Domenico Facchin Renato, Rebellato Luca, Ghidina Marco, Bianco Giulia, Bernardelli Emanuela, Miconi Antonella, Zorzin Anna Fantasia, Gregori Dario
S.O.C. Cardiologia e Fondazione IRCAB, Azienda Sanitaria Universitaria Friuli Centrale, Udine.
S.O.C. Cardiologia, Azienda Sanitaria Universitaria Isontino-Giuliana, Trieste.
G Ital Cardiol (Rome). 2021 Jun;22(6):496-508. doi: 10.1714/3612.35935.
The pacemaker (PM) and implantable cardioverter-defibrillator (ICD) Registry of the Italian Association of Arrhythmology and Cardiac Pacing (AIAC) monitors the main epidemiological data in real-world practice. The survey for the 2019 activity collects information about demographics, clinical characteristics, main indications for PM/ICD therapy and device types from the Italian collaborating centers.
The Registry collects prospectively national PM and ICD implantation activity on the basis of European cards.
PM Registry: data about 22 889 PM implantations were collected (19 621 first implants and 3268 replacements). The number of collaborating centers was 173. Median age of treated patients was 81 years (75 quartile I; 87 quartile III). ECG indications included atrioventricular conduction disorders in 33.3% of first PM implants, sick sinus syndrome in 16.4%, atrial fibrillation plus bradycardia in 11.6%, other in 38.7%. Among atrioventricular conduction defects, third-degree atrioventricular block was the most common type (18.3% of first implants). Use of single-chamber PMs was reported in 25.5% of first implants, of dual-chamber PMs in 67.1%, of PMs with cardiac resynchronization therapy (CRT) in 1.5%, and of single lead atrial-synchronized ventricular stimulation (VDD/R PMs) in 5.8%. ICD Registry: data about 17 328 ICD implantations were collected (12 129 first implants and 5199 replacements). The number of collaborating centers was 425. Median age of treated patients was 71 years (62 quartile I; 77 quartile III). Primary prevention indication was reported in 83.1% of first implants, secondary prevention in 16.9% (cardiac arrest in 5.9%). A single-chamber ICD was used in 26.1% of first implants, dual-chamber ICD in 28.0% and biventricular ICD in 45.9%.
The PM and ICD Registry appears fundamental for monitoring PM and ICD utilization on a large national scale with rigorous examination of demographics and clinical indications. The PM Registry showed stable electrocardiographic and symptom indications, with an important prevalence of dual-chamber pacing. The use of CRT-PM regards a very limited number of patients. The ICD Registry documented a large use of prophylactic and biventricular ICD, reflecting a favorable adherence to trials and guidelines in clinical practice. In order to increase and optimize the cooperation of Italian implanting centers, online data entry (https://www.aiac.it/riprid) should be adopted at large scale.
意大利心律失常与心脏起搏协会(AIAC)的起搏器(PM)和植入式心律转复除颤器(ICD)注册登记处监测实际临床中的主要流行病学数据。2019年活动调查从意大利各合作中心收集了有关人口统计学、临床特征、PM/ICD治疗主要适应证及设备类型的信息。
该注册登记处基于欧洲卡片前瞻性地收集全国范围内的PM和ICD植入活动数据。
PM注册登记处:收集到22889例PM植入数据(19621例首次植入和3268例更换)。合作中心数量为173个。接受治疗患者的中位年龄为81岁(四分位数间距I为75岁;四分位数间距III为87岁)。心电图适应证方面,首次PM植入中33.3%为房室传导障碍,16.4%为病态窦房结综合征,11.6%为心房颤动合并心动过缓,38.7%为其他情况。在房室传导缺陷中,三度房室传导阻滞是最常见类型(占首次植入的18.3%)。首次植入中25.5%报告使用单腔PM,67.1%使用双腔PM,1.5%使用心脏再同步治疗(CRT)的PM,5.8%使用单导联心房同步心室刺激(VDD/R PM)。ICD注册登记处:收集到17328例ICD植入数据(12129例首次植入和5199例更换)。合作中心数量为425个。接受治疗患者的中位年龄为71岁(四分位数间距I为62岁;四分位数间距III为77岁)。首次植入中83.1%报告为一级预防适应证,16.9%为二级预防(心脏骤停占5.9%)。首次植入中26.1%使用单腔ICD,28.0%使用双腔ICD,45.9%使用双心室ICD。
PM和ICD注册登记处对于在全国范围内大规模监测PM和ICD的使用情况、严格审查人口统计学和临床适应证显得至关重要。PM注册登记处显示心电图和症状适应证稳定,双腔起搏占重要比例。CRT-PM的使用涉及患者数量非常有限。ICD注册登记处记录了预防性和双心室ICD的大量使用,反映出临床实践中对试验和指南的良好遵循情况。为了加强和优化意大利植入中心的合作,应大规模采用在线数据录入(https://www.aiac.it/riprid)。